Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Celimene is a venture capital firm based in Paris, France, focusing on early-stage investments and advisory services in mergers and acquisitions (M&A). The firm targets sectors such as healthcare, biotech, fintech, web3, and consumer technology. They have a portfolio of four companies and emphasize a transformative approach to M&A.
Celimene invests in pre-seed to Series B companies, particularly in health and technology sectors. Their investment strategy includes providing advisory services in M&A, aiming for long-term growth and innovation in their portfolio companies.
Notable companies in Celimene's portfolio include CellProthera, which focuses on innovative health solutions; Biofuture, dedicated to advancements in biotechnology; COINSTATS, a cryptocurrency portfolio management platform; and Wakie, details of which are unspecified.
Email your pitch deck to contact@celimenepartners.com for consideration.
Celimene often leads investment rounds, particularly in early-stage companies where they can provide both capital and strategic advisory.
Celimene is open to follow-on investments, especially if the company aligns with their focus on health and technology sectors and demonstrates growth potential.
Specific details about the size of Celimene's current fund are not publicly available.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.